4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000031
Director sold 2,119 shares at $30.10 ($63,782)
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-13 | Sale : show line 1 in the form | −2,119 | $30.10 | $63,782 | 143,002 | D |
| Open-market sales · 2,119 sh · avg $30.10 · $63,782 | ||||||
Loading xslF345X03/wf-form4_167650571634751.xml…